Company profile for Help Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Help Therapeutics, founded in 2016, is the first in China to use induced pluripotent stem cell (iPSC) technologies to develop a new generation of universal cell therapy products.Our mission is to treat clinically incurable degenerative diseases and deliver transformative treatments in oncology. Help Therapeutics is at the forefront of the world's technology in terms of cell mass production and quality assurance. Its fully aut...
Help Therapeutics, founded in 2016, is the first in China to use induced pluripotent stem cell (iPSC) technologies to develop a new generation of universal cell therapy products.Our mission is to treat clinically incurable degenerative diseases and deliver transformative treatments in oncology. Help Therapeutics is at the forefront of the world's technology in terms of cell mass production and quality assurance. Its fully automated production line has reached the international leading position, improving the quality and stability of cellular products while significantly reducing production costs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
568 Longmian Avenue, Building 1, 3rd Floor, Jiangning District, Nanjing, Jian...
Telephone
Telephone
+025 87177801
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/help-therapeutics-announces-fda-clearance-of-ind-application-for-universal-ipsc-derived-hicm-188-cell-therapy-for-the-treatment-of-end-stage-heart-failure-302282661.html

PR NEWSWIRE
22 Oct 2024

https://www.prnewswire.com/news-releases/help-therapeutics-announces-ind-approval-of-first-universal-ipsc-derived-cardiomyocyte-therapy-for-end-stage-heart-failure-in-china-301732952.html

PR NEWSWIRE
30 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty